The global orthopedic sector is evolving rapidly as aging populations and sedentary lifestyles contribute to the rising demand for joint replacements and spinal surgeries. According to Expert Market Research, the bone cement market reached a value of USD 1,756.90 million in 2024. Supported by growing orthopedic surgical volumes and innovations in material science, the market is projected to grow at a CAGR of 6.50% during 2025–2034, reaching approximately USD 3,297.94 million by 2034.

Bone Cement Market Size

Bone cement plays a vital role in anchoring implants during orthopedic procedures such as total hip arthroplasty (THA), total knee arthroplasty (TKA), vertebroplasty, and kyphoplasty. The rising incidence of degenerative bone disorders like osteoarthritis and osteoporosis is a key factor fueling market growth. Additionally, the increasing geriatric population, particularly in high-income and emerging countries, is contributing to greater surgical demand.

Bone Cement Market Share

Regional Insights

  • North America leads the global bone cement market, owing to the high volume of orthopedic procedures, advanced healthcare systems, and widespread adoption of PMMA-based bone cements.

  • Europe is another major region, driven by increasing aging populations and public healthcare reimbursement policies.

  • Asia Pacific is poised for the fastest growth, attributed to expanding medical infrastructure and the increasing accessibility of orthopedic care in countries like China, India, and Japan.

Segmental Highlights

  • Polymethyl Methacrylate (PMMA) dominates the product segment, widely used due to its excellent mechanical strength and bonding properties.

  • Among applications, arthroplasty accounts for a significant share, reflecting the high demand for hip and knee replacement surgeries.

Bone Cement Market Growth & Trends

Key Growth Drivers

  • Rising Surgical Volumes: Increasing incidences of bone fractures, trauma cases, and degenerative diseases are leading to more procedures requiring cement-based fixation.

  • Technological Advancements: Development of antibiotic-loaded bone cements and bioresorbable formulations is expanding product utility and reducing post-operative complications.

  • Aging Demographics: The growing elderly population, particularly those above 65 years, presents a key consumer base for joint replacement and spinal stabilization procedures.

Emerging Trends

  • Minimally Invasive Procedures: The rising adoption of vertebroplasty and kyphoplasty to treat compression fractures is propelling demand for injectable bone cement solutions.

  • Customized Bone Cement: Manufacturers are increasingly offering patient-specific formulations, improving surgical outcomes and reducing allergic or inflammatory responses.

  • Regenerative Approaches: Bioactive and calcium phosphate-based bone cements are gaining traction due to their compatibility with bone remodeling and healing processes.

Learn more about the material’s composition and function in orthopedic procedures in this detailed Wikipedia article on bone cement.

Bone Cement Market Case Studies & News

  • In 2023, Stryker Corporation launched its SmartRobotics™ Cementless Knee System, integrating bone cement alternatives with robotic assistance for precision placement.

  • Zimmer Biomet announced the expansion of its Antibiotic-loaded Bone Cement (ALBC) product line to address infection risks in revision surgeries.

  • Heraeus Medical continues to lead with its PALACOS® R+G, one of the most widely used cements in joint arthroplasty with integrated gentamicin.

  • DJO, LLC entered a strategic partnership with Teknimed to co-develop high-viscosity cement formulations suitable for minimally invasive spine procedures.

These developments reflect the market's emphasis on product safety, longevity, and infection control.

Bone Cement Market Analysis

Competitive Landscape

The market is moderately consolidated, with established companies focusing on R&D, geographic expansion, and product portfolio diversification. Collaborations with hospitals and surgical centers, especially in emerging markets, are key strategies for market penetration.

Market Dynamics

  • Opportunities: Increased investment in emerging markets, rising medical tourism, and demand for biodegradable bone cements present strong growth potential.

  • Challenges: Potential complications such as cement leakage, thermal necrosis, and allergic reactions pose clinical concerns and may impact adoption rates.

Regulatory Overview

Regulatory bodies such as the U.S. FDA and European Medicines Agency (EMA) enforce strict guidelines for the approval and quality assurance of bone cements, ensuring patient safety and product efficacy.

Bone Cement Market Segmentation

By Product

  • Polymethyl Methacrylate (PMMA) Cement

  • Calcium Phosphate Cement (CPC)

  • Glass Polyalkenoate Cement

By Application

  • Arthroplasty

  • Kyphoplasty

  • Vertebroplasty

  • Others

By End User

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centres

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

Bone Cement Market Key Players

  • DJO, LLC

  • Stryker Corporation

  • Smith & Nephew Plc

  • Arthrex, Inc.

  • Tecres S.p.A.

  • Heraeus Holding GmbH

  • Teknimed

  • Zimmer Biomet

  • DePuy Synthes

These companies are investing heavily in product development, clinical trials, and partnerships to enhance their competitive advantage and meet evolving surgical needs.

The bone cement market is expected to witness robust growth over the coming decade, supported by the rising burden of orthopedic conditions, technological innovation, and increasing demand for minimally invasive surgeries. As manufacturers focus on safety, biocompatibility, and performance, bone cement solutions will continue to play a critical role in ensuring successful orthopedic and spinal interventions. For deeper insights and data-backed projections, refer to the full study by Expert Market Research.

Find More Report:

CDMO Market trend

Liver Fibrosis Drug Pipeline Analysis share

Juvenile Macular Degeneration (JMD) Drug Pipeline Analysis trend